Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder
Conditions
GRIN-related Neurodevelopmental Disorder
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
UCLA Health - Ronald Reagan UCLA Medical Center, Los Angeles, California, United States
Lucile Packard Children's Hospital, Palo Alto, California, United States
Children's Hospital Colorado - Anschutz Medical Campus, Aurora, Colorado, United States
Children's National Hospital, Washington D.C., District of Columbia, United States
Nicklaus Children's Hospital, Miami, Florida, United States
Contact: Study coordinator (Dainelys Pena Rodriquez) · dainelys.penarodriguez@nicklaushealth.org · 786-624-3547Pediatric Neurology and Epilepsy, Winter Park, Florida, United States
Contact: Study coordinator (Denise Hubert) · dhubert@pediatricneurologyandepilepsy.com · 407-293-1122Iowa Health Care - Pediatric Neurology & Specialty Clinic, Iowa City, Iowa, United States
Boston Children's Hospital, Boston, Massachusetts, United States
Northeast Regional Epilepsy Group (NEREG) - Hackensack, Hackensack, New Jersey, United States
Columbia University - Harkness, New York, New York, United States
Duke Health-Duke Children's Hospital & Health Center, Durham, North Carolina, United States
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Child Neurology Consultants of Austin - South Austin, Austin, Texas, United States
The University of Texas Southwestern Medical Center (UTSW), Dallas, Texas, United States
UTHealth Houston, Houston, Texas, United States
Seattle Children's Hospital, Seattle, Washington, United States
UZ Brussel, Brussels, Belgium
Contact: Principal Investigator (Ine Hoogwijs)Centre Hospitalier Universitaire d'Angers (CHU Angers), Angers, France
Contact: Principal Investigator (Patrick Van Bogaert)Hospices Civils De Lyon, Bron, France
Contact: Principal Investigator (Eleni Panagiotakaki)Hôpital Necker Enfants Malades, Paris, France
Contact: Principal Investigator (Rima Nabbout)CHU Toulouse - Hôpital Purpan, Toulouse, France
Contact: Principal Investigator (Caroline Hachon Le Camus)Universitatsmedizin Greifswald Klinik und Poliklinik fur Frauenheilkunde und Geburtshilfe, Greifswald, Germany
Contact: Principal Investigator (Astrid Bertsche)Klinik und Policlinik fur Kinder - und Jugendmedizin, Leipzig, Germany
Contact: Principal Investigator (Andreas Merkenschlager)Azienda Ospedaliera Universitaria Meyer IRCCS, Florence, Viale Pieraccini, Italy
Contact: Principal Investigator (Renzo Guerrini)IRCCS Fondazione Istituto Neurologico Nazionale Casimiro Mondino, Pavia, Italy
Contact: Principal Investigator (Valentina De Giorgis)Ospedale Pediatrico Bambino Gesu, Roma, Italy
Contact: Principal Investigator (Nicola Specchio)Nicola Pietrafusa (Sub-investigator)Erasmus MC (Erasmus Universitair Medisch Centrum Rotterdam), Rotterdam, South Holland, Netherlands
Contact: Principal Investigator (Danielle Veenma)Suzanna Koudijs (Sub-investigator)Institute of Polish Mother's Health Center (Instytut Centrum Zdrowia Matki Polki), Lodz, Poland
Contact: Principal Investigator (Lukasz Przyslo)University Children's Hospital, Ljubljana, Slovenia
Contact: Principal Investigator (Damjan Osredkar)Hospital Sant Joan de Deus, Esplugues de Llobregat, Barcelona, Spain
Contact: Principal Investigator (Angeles Garcia Cazorla)Juan Lascano Nazareno (Sub-investigator)Sheffield Children's Hospital NHS Foundation Trust, Sheffield, South Yorkshire, United Kingdom
Contact: Principal Investigator (Archana Desurkar)Royal Hospital for Children Glasgow, Glasgow, United Kingdom
Contact: Principal Investigator (Sameer Zuberi)Great Ormond Street Hospital For Children NHS Foundation Trust, London, United Kingdom
Contact: Principal Investigator (Amy McTague, MD)
Study leads
Stephen Tisi
Study Director
GRIN Therapeutics, Inc.
Russell Chin
Study Director
GRIN Therapeutics, Inc.